← Back to Clinical Trials
Recruiting NCT06857838

NCT06857838 Myocardialbridge Bypass Graft Surgery Efficacy Verification

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06857838
Status Recruiting
Phase —
Sponsor Xi'an International Medical Center Hospital
Condition Myocardial Bridge of Coronary Artery
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2020-01-01
Primary Completion 2030-12-31

Trial Parameters

Condition Myocardial Bridge of Coronary Artery
Sponsor Xi'an International Medical Center Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2020-01-01
Completion 2030-12-31
Interventions
MBBGMB CABGMB unroof

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected to verify the effectiveness of the surgery.

Eligibility Criteria

Inclusion Criteria: * Patients with myocardialbridge requiring drug therapy or surgical intervention. Exclusion Criteria: * patients with myocardialbridge not requiring drug therapy or surgical intervention, or unwilling to be enrolled for any reason

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MYOCARDIAL BRIDGE OF CORONARY ARTERY TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology